Plaintiffs’ law firms have begun airing ads highlighting a recent medical study finding a possible link between the erectile dysfunction (ED) drug Viagra and an increased risk for melanoma -- the most dangerous form of skin cancer. These firms have sponsored over 2,000 ads in the first four months of this year targeting men who took erectile dysfunction drugs and later developed the disease. Read full article.
Following months of declining advertising, spending on ads soliciting plaintiffs for lawsuits targeting the blood thinner Pradaxa jumped by over 7,000% in March. The increase launched the drug into the top ten of all drugs and devices featured in mass tort ads that month. The surprising ad push comes ten months after Pradaxa manufacturer Boehringer Ingelheim agreed to pay $650 million to settle the majority of lawsuits filed over the drug which has been linked to more than 500 patient deaths. Read full article.
Monthly mass tort ad spending targeting the anti-nausea drug Zofran and its manufacturer GlaxoSmithKline, increased by over 8,000% in February -- the largest spike for any drug or medical device featured in mass tort ads in over 6 months. Twenty-five law firms sponsored over 1,300 ads featuring Zofran last month at a combined cost of approximately $2 million. By comparison, under $25,000 was spent to air fewer than 200 ads in January. Read full article.
Estimated spending on mass tort advertising targeting the Infuse Bone Graft product manufactured by Medtronic increased by over 800% in January over December. The over ninefold increase amounted to the most spent on these ads since September. The majority of the Infuse Bone Graft ads in January aired on local broadcast TV channels in the Minneapolis media market. The Brown & Crouppen law firm spent nearly $27,000 to air 267 ads there. Read full article.
The recent arrest of New York Assembly Speaker Sheldon Silver on charges of bribery related to mesothelioma and asbestos litigation has called attention to the intense and expensive competition for clients in this lucrative area of mass tort litigation. Nowhere has this battle played out more prominently than in TV advertisements broadcast across the country at all hours of the day and night. While drug and medical device mass tort advertising declined in December, mesothelioma ad spending increased 15% and total spending was greater than that spent on ads targeting the top 11 drugs combined. Read full article.